Back to search
Limb Girdle Muscular Dystrophy Type 2C
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Limb Girdle Muscular Dystrophy Type 2C trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Limb Girdle Muscular Dystrophy Type 2C trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset P…
The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electron…
The purpose of ATA-003-GSAR study is to evaluate the safety and tolerability of a single intravenous infusion of ATA-200 in pediatric patients with limb girdle…
This study will follow participants who are screened and confirmed with a genetic diagnosis of Limb-girdle muscular dystrophy type 2E (LGMD2E/R4), Limb-girdle m…